The Wall Street Journal
Roughly one in three Medicare beneficiaries diagnosed with prostate cancer today gets a sophisticated form of radiation therapy called IMRT. Eight years ago, virtually no patients received the treatment.
The story behind the sharp rise in the use of IMRT—which stands for
intensity-modulated radiation therapy—is about more than just the rapid
adoption of a new medical technology. It's also about financial
incentives... Read More